Influence of muramyl dipeptide on established experimental arthritis in rats. - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Agents and actions. Supplements Année : 1991

Influence of muramyl dipeptide on established experimental arthritis in rats.

Résumé

The effects of MDP, a potent inducer of cytokines, were studied in four batches of Wistar Furth rats with established experimental arthritis. Arthritic rats were given a daily sc injection of 10, 100, 200 or 400 micrograms MDP respectively. Muramyl dipeptide increased the severity of clinical events in a dose-dependent manner, with the exception of the 10 micrograms dose which was ineffective. The levels of anti-collagen antibodies were not however significantly enhanced by MDP. Radiological lesions and histological changes were maximal at high dosage regimens. Paradoxically, the acute phase reactive alpha 1 glycoprotein was little affected by MDP treatment.
Fichier non déposé

Dates et versions

hal-01707374 , version 1 (12-02-2018)

Identifiants

Citer

J Jouzeau, E Drelon, G. Gillet, B Bannwarth, P. Fener, et al.. Influence of muramyl dipeptide on established experimental arthritis in rats.. Agents and actions. Supplements, 1991, pp.191-5. ⟨10.1007/978-3-0348-7405-2_26⟩. ⟨hal-01707374⟩
25 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More